4-tert-Butylbenzoyl chloride → HCID 68807165, compound
Reaction equation
[CH2:1]([CH:3]([N:6]1[CH2:11][CH2:10][CH:9]([CH2:12][C:13]([NH:15][OH:16])=[NH:14])[CH2:8][CH2:7]1)[CH2:4][CH3:5])[CH3:2].[C:17]([C:21]1[CH:29]=[CH:28][C:24]([C:25]([Cl:27])=O)=[CH:23][CH:22]=1)([CH3:20])([CH3:19])[CH3:18]>>[ClH:27].[CH2:1]([CH:3]([N:6]1[CH2:11][CH2:10][CH:9]([CH2:12][C:13]2[N:14]=[C:25]([C:24]3[CH:28]=[CH:29][C:21]([C:17]([CH3:20])([CH3:19])[CH3:18])=[CH:22][CH:23]=3)[O:16][N:15]=2)[CH2:8][CH2:7]1)[CH2:4][CH3:5])[CH3:2]Participants
3
Procedure
The title compound was prepared by a similar procedure to that described in Example 12, starting from 2-((1-ethylpropyl)piperidin-4-yl)-N-hydroxyacetamidine and 4-tert-butylbenzoyl chloride.
Sources & evidence
- ORD record
- ord-ddaf68d78aba4b98bdbd30dd73bd8099
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07799924B2
Reaction notes
Loading…